1. Metabolic Enzyme/Protease NF-κB
  2. Glycosidase Amylases NF-κB
  3. Chrysin-7-O-glucuronide

Chrysin-7-O-glucuronide is a flavonoid found in Scutellaria baicalensis. Chrysin-7-O-glucuronide inhibits α-glucosidase and α-amylase with IC50 values of 612.13 and 980.73 μg/mL. Chrysin-7-O-glucuronide suppresses NF-κB signaling activity. Chrysin-7-O-glucuronide scavenges free radicals, acts as a tight junction protector, and mitigates intestinal mucosal barrier injury. Chrysin-7-O-glucuronide can be used for the research of type 2 diabetes and severe acute pancreatitis-induced intestinal mucosal barrier injury.

For research use only. We do not sell to patients.

Chrysin-7-O-glucuronide

Chrysin-7-O-glucuronide Chemical Structure

CAS No. : 35775-49-6

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
1 mg In-stock
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of Chrysin-7-O-glucuronide:

Top Publications Citing Use of Products

1 Publications Citing Use of MCE Chrysin-7-O-glucuronide

View All NF-κB Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Chrysin-7-O-glucuronide is a flavonoid found in Scutellaria baicalensis. Chrysin-7-O-glucuronide inhibits α-glucosidase and α-amylase with IC50 values of 612.13 and 980.73 μg/mL. Chrysin-7-O-glucuronide suppresses NF-κB signaling activity. Chrysin-7-O-glucuronide scavenges free radicals, acts as a tight junction protector, and mitigates intestinal mucosal barrier injury. Chrysin-7-O-glucuronide can be used for the research of type 2 diabetes and severe acute pancreatitis-induced intestinal mucosal barrier injury[1][2].

In Vitro

Chrysin-7-O-glucuronide (0-2 mg/mL; 2 h) inhibits yeast α-glucosidase with an IC50 of 612.13 μg/mL[1].
Chrysin-7-O-glucuronide (0-2 mg/mL; 20 min) inhibits porcine pancreatic α-amylase with an IC50 of 980.73 μg/mL[1].
Chrysin-7-O-glucuronide (16 μM; 24 h) restores ZO-1 expression and tight junction structure in TNF-α-treated IEC-6 cells[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Immunofluorescence[1]

Cell Line: IEC-6 cells
Concentration: 16 μM
Incubation Time: 24 h pretreated before TNF-α
Result: Increased the fluorescence of ZO-1.
In Vivo

Chrysin-7-O-glucuronide (20 mg/kg; i.p.; every 6 hours) significantly ameliorates SAP-induced intestinal mucosal barrier injury in rats by suppressing NF-κB inflammatory signaling, reducing intestinal pathological damage, restoring tight junction integrity, and lowering systemic intestinal injury marker levels[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Sprague-Dawley (male, 7-8 weeks old, 250 g, severe acute pancreatitis induced via intrapancreaticobiliary duct infusion of 5% sodium taurocholate solution)[2]
Dosage: 20 mg/kg
Administration: i.p.; every 6 h
Result: Significantly alleviated intestinal epithelial structural abnormalities, as evidenced by reduced intestinal pathological scores.
Partially restored goblet cell numbers compared to SAP controls.
Decreased serum levels of intestinal injury markers (D-lactic acid, diamine oxidase, I-FABP, Zonulin) and serum endotoxin levels.
Restored expression of the tight junction protein ZO-1 in intestinal epithelia.
Reduced intestinal protein levels of HMGB1 and IL-1β.
Decreased the proportion of p-p65 and p-IκBα-positive intestinal cells, indicating suppressed NF-κB inflammatory signaling.
Molecular Weight

430.36

Formula

C21H18O10

CAS No.
Appearance

Solid

Color

Off-white to yellow

SMILES

O=C1C2=C(O)C=C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)C=C2OC(C4=CC=CC=C4)=C1

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility
In Vitro: 

DMSO : 50 mg/mL (116.18 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.3236 mL 11.6182 mL 23.2364 mL
5 mM 0.4647 mL 2.3236 mL 4.6473 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (5.81 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (5.81 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.47%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.3236 mL 11.6182 mL 23.2364 mL 58.0909 mL
5 mM 0.4647 mL 2.3236 mL 4.6473 mL 11.6182 mL
10 mM 0.2324 mL 1.1618 mL 2.3236 mL 5.8091 mL
15 mM 0.1549 mL 0.7745 mL 1.5491 mL 3.8727 mL
20 mM 0.1162 mL 0.5809 mL 1.1618 mL 2.9045 mL
25 mM 0.0929 mL 0.4647 mL 0.9295 mL 2.3236 mL
30 mM 0.0775 mL 0.3873 mL 0.7745 mL 1.9364 mL
40 mM 0.0581 mL 0.2905 mL 0.5809 mL 1.4523 mL
50 mM 0.0465 mL 0.2324 mL 0.4647 mL 1.1618 mL
60 mM 0.0387 mL 0.1936 mL 0.3873 mL 0.9682 mL
80 mM 0.0290 mL 0.1452 mL 0.2905 mL 0.7261 mL
100 mM 0.0232 mL 0.1162 mL 0.2324 mL 0.5809 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Chrysin-7-O-glucuronide
Cat. No.:
HY-N2376
Quantity:
MCE Japan Authorized Agent: